Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population.

OBJECTIVE Constitutively activating mutations of the thyrotropin receptor (TSHR) have been found in the majority of autonomously functioning thyroid nodules (AFTNs) in European patients. The reported frequency of these mutations varies among reports but amounts to 50-80%. To date, only one such mutation responsible for AFTNs has been identified in the Japanese population and the pathogenic role of such mutations in Japanese AFTNs has been questioned. In the present study, we evaluated the frequency of activating mutations in the TSHR and G(alpha)s in 10 Japanese AFTNs. DESIGN Genomic DNA was extracted from fresh frozen tissue. The TSHR and the almost entire sequence of the gene coding for the alpha subunit of Gs have been amplified and sequenced. RESULTS In sequence analysis, four mutations in the TSHR (T632A, I486M, M453T and L512R) were found. To complete our analysis, we searched mutations in the gene coding for the alpha subunit of Gs, in the samples negative for TSHR mutations. In one case a mutation (R201H) affecting GTPase activity was found. CONCLUSIONS If we focus on the solitary nodules, we obtain the same mutation proportion as in European patients (70%). The absence of TSHR and G(alpha)s mutations in a significant proportion of autonomous adenomas in multinodular goiters suggests that other causes may also play a role in the genesis of these lesions.

[1]  Knut Krohn,et al.  Detection of thyroid-stimulating hormone receptor and Gsα mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis , 2001, Journal of Molecular Medicine.

[2]  S. Schurmans,et al.  Low TSH Requirement and Goiter in Transgenic Mice Overexpressing IGF-I and IGF-I Receptor in the Thyroid Gland. , 2001, Endocrinology.

[3]  T. Jørgensen,et al.  Thyroid disorders in mild iodine deficiency. , 2000, Thyroid : official journal of the American Thyroid Association.

[4]  T. Mori,et al.  A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. , 2000, European journal of endocrinology.

[5]  A. Pinchera,et al.  Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  G. Thompson,et al.  Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. , 1999, The Journal of clinical endocrinology and metabolism.

[7]  R. Paschke,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Clonal Origin of Toxic Thyroid Nodules with Constitutively Activating Thyrotropin Receptor Mutations* , 2022 .

[8]  R. Paschke,et al.  Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. , 1997, The Journal of clinical endocrinology and metabolism.

[9]  P. Rocmans,et al.  Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. , 1997, The Journal of clinical endocrinology and metabolism.

[10]  J. Parma,et al.  Constitutive activation of the TSH receptor by spontaneous mutations affecting the N‐terminal extracellular domain , 1997, FEBS letters.

[11]  J. Parma,et al.  Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. , 1997, The Journal of clinical endocrinology and metabolism.

[12]  M. Derwahl Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[13]  S. Nagataki,et al.  Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan. , 2009, Thyroid : official journal of the American Thyroid Association.

[14]  J. Fagin,et al.  Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. , 1996, The Journal of clinical endocrinology and metabolism.

[15]  F. Cetani,et al.  Oncogenic mutations in thyroid adenoma: methodological criteria. , 1996, European journal of endocrinology.

[16]  M. Polak,et al.  A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  S. Filetti,et al.  Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. , 1996, The Journal of clinical endocrinology and metabolism.

[18]  N. Ishikawa,et al.  Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. , 1995, The Journal of clinical endocrinology and metabolism.

[19]  C. Als,et al.  [Toxic adenomas of the thyroid gland becoming less frequent in Berne]. , 1995, Schweizerische medizinische Wochenschrift.

[20]  S. Swillens,et al.  Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. , 1995, Molecular endocrinology.

[21]  A. Porcellini,et al.  Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. , 1994, The Journal of clinical endocrinology and metabolism.

[22]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[23]  J. Parma,et al.  The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.

[24]  J. Dumont,et al.  Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. , 1992, Physiological reviews.

[25]  E. Kawasaki,et al.  Two G protein oncogenes in human endocrine tumors. , 1990, Science.

[26]  J. Jauniaux,et al.  The cyclic AMP-mediated stimulation of cell proliferation. , 1989, Trends in biochemical sciences.

[27]  David Ninan,et al.  Thyroid Disorders , 1985, Absolute Obstetric Anesthesia Review.